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RCA. Failure of RV branch reperfusion was associated with lack of early
recovery of RV wall motion (baseline RVFW motion 3.7 + 0.4 to 3.3 + 0.7
at 1 hour and 3.1 + 0.6 at 1 day) and global RV performance (baseline RV
FAC 24 + 6% to 25 + 7% at 1 hour and 27 + 7% at 1 day). Furthermore,
in 5 of these 7 (71%) pts, cardiogenic shock developed despite intact LV
function (mean LVEF 49 + 3%) leading to early death within 48 hours in all
such cases. These observations demonstrate that primary PTCA resulting
in successful RV branch reperfusion leads to prompt and complete recovery
of RV performance, and influences clinical outcome. In contrast, inability to
restore flow to the RV branches is associated with lack of recovery of RV
function and poor clinical outcome. (’p < 0.05).
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Thrombolysis
C.McLean, M. Rizzo, K. Ryan, C. McCabe, C. Cannon, M. Gibson, for the
TIMI 10A investigators. West Roxbury VAMedical Center and Brigham &
Women’s Hospital, Boston, MA, USA
The presence of abnormally slow flow in non-culprit arteries after thrombol-
ysis has previously been described, & the goal was to determine the rela-
tionship between non-culprit flow &other angiographic variablea. The frames
required fordyeto reach standardized distal landmarks were munted, & LAD
frame counts were divided by 1.7 to correct for their longer length (Corrected
TIMI Frame Count or CTFC). The non-culprit CTFC improved from 32.5 +
18.1 frames (n= 60) at 60 min. after TNK administration in TIMI IOA to 29.4
+ 13.6 (n = 146) frames at 90 min. (p = 0.006), & the 90 min. value was
slower than that previously reported for normal arteries in the abence of
acute Ml (21.0 + 3.1, n = 78, p < 0.0001). Failure to achieve TIMI 3 flow
in the culprit artery waa associated with alower non-culprit flow at 90 min.:
25.5 + 11.1 (n = 69) vs 33.1 + 14.8 frames (n = 75) (p < 0.001). Increased
normal reference segment diameters in both the non-culprit (p = 0.007) &
culprft (p = 0.03) arteries were both correlated with slower 90 min. non-culprit
CTFCS.Left dominant systems were associated with slower non-culprit flow
at 90 min.: 36.2 + 16.3 (n = 20) vs 28.8 + 13.3 (n = 106), p = 0.03. Increased
length of the artery distal to the culprit stenosis was correlated with slower
nomculprit flow (p = 0.04) as was reduced stroke volume (p = 0.04) at 90
min. Cone/uaiona:These obsewations confirm the presence of delayed flow
in non-culprit arteriea at 90 minutes after thrombolysis which appeara to be
associated with both slower flow in the culprit artery & increased myocar-
dial territory supplied by the culprit artery (i.e. increased arterial diameter&
increased artery length distal to the culprit artery stenosis).
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Intrscoronary Thrombus in Pstisnts Presenting to a
Emergency Department with Possible Acute
Coronary Syndromee
A.F. Sonel, Y. Gawad, L. Perkins, R.L. Wilensky. Knsnner?hrstitute of
Cardiology Indianapolis, USA, Universifyof Pennsylvania Medical Centec
Phi/ade/pfria, USA
Varying degrees of intracoronary thrombus formation and myocyte destruc-”
tion occur in unstable angina (UA) and myocardial infarction (Ml). A panel of
markers were determined in 99 patients presenting with chest pain thought
to be due to possible acute corona~ ischemia. This paneI included serum
for troponin I (Tnl), myosin light chain 1 (MLCI), myoglobin (Mb) and spot
urine for fibrinopeptide A (FPA) upon presentation and at 4 hours. Patients
discharged from the Emergency Department were seen within 46 hours. The
final diagnoses determined independent of the study markers were: Ml 11
patients, UA31 patients, stable angina ornon-cardiac chest pain 57patients.
Results were (Sensitivity, positive predictive value, negative predictive value
and significance, respectively):
Ml Ml 0, 11A
c19465 Less Myocardisl but More Cerebral Ischemic Evente
in African Americans Than Caucasians With Acute
Coronary Syndromes: Results from GUSTO-II
D.J. Moliterno, C.A. Asher, R.M, Califf, K,A. Clark, A.D. Guerci, E.J. Topol,
for the GUST041B Investigators. The C/eve/and C/irricFoundation,
C/eve/and, OH, USA
Several reports have identified differences between African Americans and
Caucasians concerning risk factors and prognosis related to atherosclerotic
heart disease, however, data comparing these races with acute coronary
syndromes is very limited. Thus, we prospectively collected data regarding
outcome and race in the GUSTO-IIB trial which compared outcomes among
patients with acute coronary syndromes randomized to heparin or hirudin.
The study included 7496 Caucasians and 245 African Americans with ECG
evidence of unstable angina or Non-Q-wave Ml. Compared to Caucesiana,
African Americans were younger (57.2 vs 65.9 yrs) but .sIgnificantly more
often female, smokers, hypertensive, and diabetic. Despite this, and pre-
senting later for treatment (6.3 vs 5.0 hrs), African Americans had a similar
mortality rate at 30 days (2.9% vs 2.7%). Among suwivors, while African
Americans were more likely to have cerebral ischemia (stroke), they were
less likely to have recurrent myocardial ischemia, refractory ischemia, or
Ml (table), African Americans were also more likely to undergo PTCA than
CABG. These findings confirm important racial differences among patients
with acute coronary syndromes, and the independent effect of race is being
quantified in a multivariable model.
30-DsYEvent AfricanAmerican (%) Caucaaian(%) p-value
Ml 3.s &2 0.132
Refractoy iachemia 6.3 24.1
CABG
<0.001
18.9 29.0
Stroke
0.034
6.5 2,0 0,035
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ECG Aftar Lytics?
M.W. Krucoff, CL. Green, K.M. Trollinger, J.E. Pope, R.A. Hanington,
C.B. Granger, E.M. Ohman, K. Neuhaus, E.J. Topol, R,M. Califf. Duke
University Medkel Center Durham, NC, LISA
ST-aegment recovery analysis from continuous 12-lead ECG monitoring has
beencorrelated with infarct artery patency,drug efficacy and ciinicaloutcome.
Most hospitals do not yet have continuous 12-lead monitoring capability. To
identify the temporal landmarks associated with key ECG changes, all 544
analyzable continuous 12-lead ECG monitor (ST-100, Mortara Instrument)
studies from AMI patients treated in the TAMI-9 (n = 196), DUCCS-2 (n = 32),
GUSTO-1(n= 217) and IMPACT-I(n= 99) trials were examined. Key ECGS
included: PEAK (ECG with most ST deviation); T50 (the first ECG showing
50% recoverysuggesting reperfusion); and STEADY (the first ECG ahowing
50’%recoverythat ia atable for >4 hours). Key ECGSwere timed from: onset
of chest pain (CP time); time of the first diagnostic ECG (DX time); and onset
of Iytic therapy (RX time). Results, as median (25th, 75th %ile) in minutes
were:
PEAK ST T50 STEADY ST
CP TIME 166 (110, 245) 209 (146, 291) 314 (219, 426)
DX TIME 55 (o, 102) 9s (64, 144) 184 (114, 316)
RX TIME 7.5 (–33, 42) 42 (13, 76) 1!23(61, 241)
Thus, despite considerable variability from patient to patient, the sampling
from an acute Ml population is: 1) about 60 minutes after the first diagnostic
ECG for PEAK ST changes 2) about 40 minutes after onset of Iytic therapy
for firet evidence of reperfusion, and 3) about 120 minutes after onaet of Iytic
therapy for stable reperfuaion.
Tnl 91,100,99 p <0,001 45,77, 100 p <0,001
MLC1 91,21,98 p= 0.003 64,56,71 p = 0,006
Mb 91,50,99 p<0.001 36,75,66 p <0.001
FPA 64,30,95 p= 0.003 36,65,66 p = 0.024
Any Markar 100,21,100 p <0.001 61,61,63 p <0,001
Markers of intramronary thrombus formation and myocyte injury show a
high negative predictive value and can differentiate UA and Ml patients from
other ceuaea of chest pain. Such a panel may impact initial riak assessment
and triage optiona.
n T,M,10946-19 Flow After Adjunctive & Rescue PTCA in TIMI 4 &
M. Gibaon, C. McLean, M. Rizzo, K. Ryan, C. Cannon, E. Braunwald, for the
TIMI 4 and TIMI 10A&B Investigators. Brigham and Women’s Hospita/,
Boston MA, USA
The freme$ for dye to reach standardized distal landmarks were counted to
arrive at the Corrected TIMI Frame Count (CTFC, an index of flow) before&
after adjunctive or reacue PTCA following thrombolysis in the TIMI 4 (TPA,
APSAC), 10A (TNK), & IOB (TNK, TPA) triala:
